CVS HEALTH CORPORATION |
Market Closed -
Other stock markets
|
Pre-market 09:00:19 | |||
| 56 USD | -0.83% |
|
56.48 | +0.85% |
| 05-08 | Argus Research Adjusts Price Target on CVS Health to $80 From $100 | MT |
| 05-08 | Mickey Mouse on Wall Street |  |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 369B 502B | Sales 2025 * | 388B 528B | Capitalization | 70.3B 95.73B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.66B 10.44B | Net income 2025 * | 8.92B 12.15B | EV / Sales 2024 * | 0.32 x |
| Net Debt 2024 * | 48.83B 66.48B | Net Debt 2025 * | 45.01B 61.29B | EV / Sales 2025 * | 0.3 x |
| P/E ratio 2024 * |
9.65
x | P/E ratio 2025 * |
8.24
x | Employees | 259,500 |
| Yield 2024 * |
4.75% | Yield 2025 * |
4.71% | Free-Float | 70.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on CVS Health Corporation
More recommendations
More press releases
More news
| 1 day | +0.85% | ||
| 1 week | +0.47% | ||
| Current month | -17.29% | ||
| 1 month | -18.41% | ||
| 3 months | -26.71% | ||
| 6 months | -18.25% | ||
| Current year | -29.08% |
1 week
54.72
57.55
1 month
53.7071.66
Current year
53.7083.25
1 year
53.7083.25
3 years
53.70111.25
5 years
51.72111.25
10 years
51.72113.65
| Managers | Title | Age | Since |
|---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 18-11-27 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 22-01-31 |
David Falkowski
CMP | Compliance Officer | - | 11-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 11-01-19 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 18-11-27 |
Mary Schapiro
BRD | Director/Board Member | 68 | 17-05-09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.92% | 17 M€ | +7.01% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 56 | -0.83% | 15,410,680 |
| 24-05-13 | 56.47 | +1.16% | 11,767,627 |
| 24-05-10 | 55.82 | +0.25% | 9,288,418 |
| 24-05-09 | 55.68 | +1.40% | 10,300,491 |
| 24-05-08 | 54.91 | -1.49% | 13,625,329 |
Delayed Quote Nyse, May 14, 2024 at 04:00 pm
More quotes
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:
- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);
- medical benefits management (25.8%);
- other (0.1%).
Calendar
2024-05-16
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
56
USD
Average target price
71.37
USD
Spread / Average Target
+27.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.08% | 70.3B | |
| +2.04% | 27.46B | |
| -7.08% | 17.8B | |
| +2.24% | 17.46B | |
| +0.93% | 15.46B | |
| +6.78% | 13.49B | |
| +8.85% | 13.06B | |
| +68.45% | 12.96B | |
| +70.12% | 12.56B | |
| +0.64% | 12.14B |
- Stock Market
- Equities
- CVS Stock